Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 16,490,000 shares, an increase of 25.3% from the March 15th total of 13,160,000 shares. Based on an average daily volume of 2,860,000 shares, […] Read this story
